Charlène Levi Selected Research

Charlène Levi Research Topics

3	Chronic Kidney Failure (Chronic Renal Failure) 09/2023 - 12/2017
2	Rare Diseases (Rare Disease) 09/2023 - 12/2017
2	Membranous Glomerulonephritis (Membranous Nephropathy) 07/2021 - 01/2021
1	Amyloidosis 09/2023
1	Kidney Diseases (Kidney Disease) 09/2023
1	Renal Insufficiency (Renal Failure) 09/2023
1	Primary hyperoxaluria type 1 01/2023
1	COVID-19 01/2022
1	Infections 01/2022
1	Nocardia Infections 08/2021
1	Disease Susceptibility (Diathesis) 01/2021
1	Heart Arrest (Cardiac Arrest) 09/2020
1	Proteinuria 09/2020
1	Death (Near-Death Experience) 09/2020
1	Acute Intermittent Porphyria (Porphyria, Acute) 09/2020
1	Acute Kidney Injury (Acute Renal Failure) 08/2020
1	Chronic Renal Insufficiency 08/2020
1	Atypical Hemolytic Uremic Syndrome 12/2017
1	Thrombotic Microangiopathies 12/2017
1	Peritonitis 01/2016
1	Arthritis (Polyarthritis) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Fanconi Syndrome (Syndrome, Fanconi) 04/2015
1	Glomerulonephritis 02/2012
1	Nephritis 02/2012

2	HLA-D AntigensIBA 07/2021 - 01/2021
2	CalpainIBA 01/2016 - 02/2012
1	AA amyloidosisIBA 09/2023
1	C-Reactive ProteinIBA 09/2023
1	lumasiranIBA 01/2023
1	VaccinesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 08/2021
1	Trimethoprim (Proloprim)FDA LinkGeneric 08/2021
1	CreatinineIBA 09/2020
1	Heme (Haem)IBA 09/2020
1	Ifosfamide FDA LinkGeneric 08/2020
1	AntibodiesIBA 12/2017
1	eculizumab FDA Link 12/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	VemurafenibIBA 04/2015
1	Fibronectins (Fibronectin)IBA 02/2012
1	calpastatinIBA 02/2012